DSM PTG, part of DSM Biomedical, a global leader in biomedical materials, today announced the company’s participation in the upcoming 2009 International Medical Devices Conference & Expo (IMD EXPO). Dedicated to medical devices design, engineering, material selections and manufacturing, the 2009 IMD EXPO will bring together the world’s leaders in engineering and technology to discuss medical devices and applications for patient care. It is being held September 14-15, 2009 at the Hotel Marriott Downtown in San Jose, California.

Nelson Cooke, Ph.D., DSM PTG’s business development manager, will lead sessions and participate in discussions focused on important issues in the medical device industry. Cooke will chair the September 15th session, “Advances in Materials Complementing Device Design,” and will co-chair a second session that same day titled “Medical Device Design and Development.”

“I am honored to be part of a conference that brings together experts from all over the globe to discuss advances in medical devices, medical materials, processes and drug delivery systems,” said Nelson Cooke. “ We have an extremely impressive line-up of speakers, panelists and exhibitors, all of whom bring unique and exciting ideas to the table. This year’s conference and expo promises to be exceptional.”

Other experts from DSM PTG who will be speaking or participating in panel discussions include:

Bob Ward; Shanger Wang, Ph.D; James Parakka; Ph.D; and Robert L. Jones, D.Sc. Topics for discussion will include the use of polymer surface activity and self assembly in medical devices, polymers providing self-assembling antimicrobial surface, degradation behavior of high strength bioabsorbable polyurethanes, surface chemical control and analysis of biomedical materials, and UHMWPE via macromolecular design.

To register to attend the 2009 IMD EXPO please visit: http://www.imdexpo.com/pages/info.html

About DSM Biomedical
DSM Biomedical develops novel materials-based solutions to meet the present and future needs of the medical device and pharmaceutical industries. Building on the expertise and strengths of DSM and its acquisition of DSM PTG (formerly The Polymer Technology Group), the company's product portfolio includes coatings, drug delivery platforms and a wide range of biomedical materials for use in short- and long-term implantable medical devices. Key product brands include Bionate® TPU and CarboSil® TSPU, two of the most extensively tested biomedical polymers ever developed. Both polymers have excellent biostability, high strength and abrasion resistance, making them candidate materials for load-bearing orthopedic implants. ComfortCoat™ hydrophilic and antimicrobial coating technology for catheters, guidewires and stent delivery systems; and Dyneema Purity®, a high-performance polyethylene fiber technology developed specifically for use in medical applications, such as orthopedic implants. The company also markets the Trancerta™ Drug Delivery approach, which is based on DSM's core strengths in polymers combined with its extensive in-house library of synthesis methods, formulation and processing techniques. For more information, visit www.dsmbiomedical.com .

DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com